SEAT
SEAT: DeFlorio Jane E. discloses securities transactions
DeFlorio Jane E. reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
LoadingLoadingLoadingSEAT
DeFlorio Jane E. reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
SEAT
Dixon Craig A. reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
SEAT
ANDERSON MARK M. reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
SEAT
Boehly Todd L reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
SEAT
Masino Julie D. reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
PACS
Murray Jason Hulse reported Sale in PACS Group, Inc.: 1620 units of Common Stock, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
GRCE
Opaleye Management Inc. reported Purchase in Grace Therapeutics, Inc.: 4256 units of Common Stock, par value $0.0001 per share, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
META
Olivan Javier reported Sale in Meta Platforms, Inc.: 946 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 5 transaction entries.
CRSP
Silver Andrew Jacob reported Grant or award in CRISPR Therapeutics AG: 25000 units of Restricted Stock Units (derivative), dated 2026-10-19. The full Form 4 contains 1 transaction entry.
PALI
Capers Julien E. reported 787,300 shares of Common Stock in PALISADE BIO, INC. as grants or awards dated 2026-10-19. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
IOT
Kirchhoff Benjamin Louis reported Sale in Samsara Inc.: 770 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
INV
Stober Eric reported 1,818,182 shares of Common Stock in Innventure, Inc. as grants or awards dated 2026-10-19. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
RAPP
Ignelzi Troy A. reported Purchase in Rapport Therapeutics, Inc.: 5500 units of Common Stock, dated 2026-10-21. The full Form 4 contains 1 transaction entry.
TTD
Green Jeffrey Terry reported Disposition to issuer in Trade Desk, Inc.: 215720 units of Employee Stock Option (Right to Buy) (derivative), dated 2026-10-19. The full Form 4 contains 8 transaction entries.
TTD
Olmstead Nathan reported Disposition to issuer in Trade Desk, Inc.: 439753 units of Employee Stock Option (Right to Buy) (derivative), dated 2026-10-19. The full Form 4 contains 2 transaction entries.
TTD
Kundra Vivek reported Disposition to issuer in Trade Desk, Inc.: 160792 units of Employee Stock Option (Right to Buy) (derivative), dated 2026-10-19. The full Form 4 contains 4 transaction entries.
ELVN
Collins Helen Louise reported Exercise or conversion in Enliven Therapeutics, Inc.: 5000 units of Common Stock, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
TTD
GRANT JAY R reported Disposition to issuer in Trade Desk, Inc.: 15512 units of Employee Stock Option (Right to Buy) (derivative), dated 2026-10-19. The full Form 4 contains 10 transaction entries.
TTD
Davis Tahnil R. reported Disposition to issuer in Trade Desk, Inc.: 8430 units of Employee Stock Option (Right to Buy) (derivative), dated 2026-10-19. The full Form 4 contains 12 transaction entries.
ELVN
Hohl Benjamin reported Exercise or conversion in Enliven Therapeutics, Inc.: 6018 units of Common Stock, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
ADEA
Kokes Mark reported Tax/exercise withholding in Adeia Inc.: 8133 units of Common Stock, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
CLMT
Lunin David reported Exercise or conversion in Calumet, Inc. /DE: 20000 units of Common Stock, par value $0.01 per share, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
MCDEARMAN JOHN reported Purchase in WILSON BANK HOLDING CO: 20 units of COMMON STOCK, dated 2026-10-21. The full Form 4 contains 1 transaction entry.
IRON
Bitterman Kevin reported Sale in Disc Medicine, Inc.: 5937 units of Common Stock, dated 2026-10-19. The full Form 4 contains 9 transaction entries.
